Peer Review History

Original SubmissionJuly 22, 2025
Decision Letter - Naser Anjum, Editor

Dear Dr. He,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 04 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Naser A. Anjum, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed: https://pubmed.ncbi.nlm.nih.gov/38775862/ https://www.mdpi.com/2311-7524/8/11/1002

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

3. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

4. In this instance it seems there may be acceptable restrictions in place that prevent the public sharing of your minimal data. However, in line with our goal of ensuring long-term data availability to all interested researchers, PLOS’ Data Policy states that authors cannot be the sole named individuals responsible for ensuring data access (http://journals.plos.org/plosone/s/data-availability#loc-acceptable-data-sharing-methods).

Data requests to a non-author institutional point of contact, such as a data access or ethics committee, helps guarantee long term stability and availability of data. Providing interested researchers with a durable point of contact ensures data will be accessible even if an author changes email addresses, institutions, or becomes unavailable to answer requests.

Before we proceed with your manuscript, please also provide non-author contact information (phone/email/hyperlink) for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If no institutional body is available to respond to requests for your minimal data, please consider if there any institutional representatives who did not collaborate in the study, and are not listed as authors on the manuscript, who would be able to hold the data and respond to external requests for data access? If so, please provide their contact information (i.e., email address). Please also provide details on how you will ensure persistent or long-term data storage and availability.

5. Thank you for stating the following financial disclosure: [the Doctoral Development Special Project of Kaili University (BSFZ202503).].

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

6. Thank you for stating the following in the Acknowledgments Section of your manuscript: [Much appreciated financial support was provided by the Doctoral Development Special Project of Kaili University (BSFZ202503).]

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [the Doctoral Development Special Project of Kaili University (BSFZ202503).].

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

7. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

8. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

9. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments:

REVIEWER #1

The manuscript entitled "Physiological and Bn-OASTL Gene Expression Responses to Cadmium Stresses in Tobacco Seedlings" presents a systematic study on the cloning and heterologous expression of the BnOASTL gene and its role in cadmium stress response. The research question is relevant, and the methodology is generally sound. Although the expected enhancement of Cd resistance and accumulation was not observed, the negative findings provide valuable insight for future studies on heavy metal stress mechanisms. The manuscript is generally well-organized and provides sufficient data to support its conclusions.

However, some issues in the abstract, introduction, methods, results discussion, and language presentation need to be addressed to further improve the manuscript's clarity, scientific rigor, and academic value. I recommend a minor revision before acceptance.

1. The title, abstract, and keywords are not fully consistent regarding the research subject, species, and gene information. For example, the title and abstract refer to Bn-OASTL and tobacco, while the keywords include “rapeseed (Brassica napus L.)” instead. Please ensure that these elements are precisely aligned and consistently reflect the main experimental system and research focus.

2. The abstract contains some ambiguous statements and lacks clear logical flow. In particular, the functional analysis of the gene did not show a significant effect in transgenic tobacco, but the discussion on the underlying mechanisms is insufficient. Furthermore, the scientific significance and future perspective of this study in the context of Cd-tolerant crop molecular design are not adequately highlighted. Please refine the abstract to clearly state the main findings (e.g., the lack of improvement in Cd tolerance/accumulation) and emphasize their scientific relevance to the field.

3. The introduction is overly lengthy and the literature review is somewhat scattered. I recommend condensing the introduction to make it more concise, with a clear focus on the scientific question and the innovative aspects of this study. Excessive background information should be removed to avoid redundancy. Please clearly articulate the rationale for selecting BnOASTL, the reason for using tobacco as the heterologous expression system, and the current knowledge gaps that this work aims to address. In addition, the introduction should include a more forward-looking discussion on the potential of the OASTL gene family in molecular breeding and heavy metal phytoremediation, highlighting future directions and scientific significance.

4. Provide more experimental details, such as specific reagent sources, PCR/qPCR conditions, and statistical methods to improve reproducibility. Ensure all primers, vectors, and key reagents are clearly described.

5. Enhance the interpretation of the results, especially the possible reasons why overexpression of BnOASTL did not improve Cd tolerance. Discuss the broader significance and possible directions for future research, such as the need for multi-gene manipulation or systems biology approaches.

6. Ensure that all figures and legends are sufficiently detailed, and clearly indicate statistical significance where applicable.

7. Please ensure that all references are properly formatted and include DOI numbers where available. Including DOIs for all cited literature is required by the journal and will improve the accessibility and traceability of your references.

REVIEWER #2

The manuscript entitled "Physiological and Bn-OASTL Gene Expression Responses to

Cadmium Stresses in Tobacco Seedlings" deal with an original subject within the plant soil interactions field. neertheless the ms at its present form is not suitable for publication:

-the title did not much the Ms. the is no physiological study it is just a monitoring of Cd and GSH contents

-in the ms authors present a work on tobacco plants however in conclusion they change to tomato???

-molecular analyses are goods however the discussion is not appropriated to the founded results. it is clear from results that theBn-OASTL Gene has no relatioship with the resistance beahavior within tobacco plant meaning thet tobacco did not use the g O-acetylserine(thiol)lyase pathway to overcome the Cd stress.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: The manuscript entitled "Physiological and Bn-OASTL Gene Expression Responses to Cadmium Stresses in Tobacco Seedlings" presents a systematic study on the cloning and heterologous expression of the BnOASTL gene and its role in cadmium stress response. The research question is relevant, and the methodology is generally sound. Although the expected enhancement of Cd resistance and accumulation was not observed, the negative findings provide valuable insight for future studies on heavy metal stress mechanisms. The manuscript is generally well-organized and provides sufficient data to support its conclusions.

However, some issues in the abstract, introduction, methods, results discussion, and language presentation need to be addressed to further improve the manuscript's clarity, scientific rigor, and academic value. I recommend a minor revision before acceptance.

1. The title, abstract, and keywords are not fully consistent regarding the research subject, species, and gene information. For example, the title and abstract refer to Bn-OASTL and tobacco, while the keywords include “rapeseed (Brassica napus L.)” instead. Please ensure that these elements are precisely aligned and consistently reflect the main experimental system and research focus.

2. The abstract contains some ambiguous statements and lacks clear logical flow. In particular, the functional analysis of the gene did not show a significant effect in transgenic tobacco, but the discussion on the underlying mechanisms is insufficient. Furthermore, the scientific significance and future perspective of this study in the context of Cd-tolerant crop molecular design are not adequately highlighted. Please refine the abstract to clearly state the main findings (e.g., the lack of improvement in Cd tolerance/accumulation) and emphasize their scientific relevance to the field.

3. The introduction is overly lengthy and the literature review is somewhat scattered. I recommend condensing the introduction to make it more concise, with a clear focus on the scientific question and the innovative aspects of this study. Excessive background information should be removed to avoid redundancy. Please clearly articulate the rationale for selecting BnOASTL, the reason for using tobacco as the heterologous expression system, and the current knowledge gaps that this work aims to address. In addition, the introduction should include a more forward-looking discussion on the potential of the OASTL gene family in molecular breeding and heavy metal phytoremediation, highlighting future directions and scientific significance.

4. Provide more experimental details, such as specific reagent sources, PCR/qPCR conditions, and statistical methods to improve reproducibility. Ensure all primers, vectors, and key reagents are clearly described.

5. Enhance the interpretation of the results, especially the possible reasons why overexpression of BnOASTL did not improve Cd tolerance. Discuss the broader significance and possible directions for future research, such as the need for multi-gene manipulation or systems biology approaches.

6. Ensure that all figures and legends are sufficiently detailed, and clearly indicate statistical significance where applicable.

7. Please ensure that all references are properly formatted and include DOI numbers where available. Including DOIs for all cited literature is required by the journal and will improve the accessibility and traceability of your references.

In summary, I recommend minor revision. The authors should carefully address the points above to enhance the scientific rigor, clarity, and academic value of the manuscript. After revision, the manuscript will be suitable for publication.

Reviewer #2: The manuscript entitled "Physiological and Bn-OASTL Gene Expression Responses to

Cadmium Stresses in Tobacco Seedlings" deal with an original subject within the plant soil interactions field. neertheless the ms at its present form is not suitable for publication:

-the title did not much the Ms. the is no physiological study it is just a monitoring of Cd and GSH contents

-in the ms authors present a work on tobacco plants however in conclusion they change to tomato???

-molecular analyses are goods however the discussion is not appropriated to the founded results. it is clear from results that theBn-OASTL Gene has no relatioship with the resistance beahavior within tobacco plant meaning thet tobacco did not use the g O-acetylserine(thiol)lyase pathway to overcome the cd stress

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

We have carefully considered each comment and made corresponding corrections, which we hope will meet with your approval. All revisions are marked in red in the revised manuscript.

Attachments
Attachment
Submitted filename: Response to Editor and Reviewers-20250924.docx
Decision Letter - Debasis Chakrabarty, Editor

Monitoring of Cd and GSH Contents and Bn-OASTL Expression in Transgenic Tobacco Seedlings in Response to Cd Stress

PONE-D-25-39819R1

Dear Dr. He,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Debasis Chakrabarty

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: (No Response)

Reviewer #3: All comments have been addressed

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: (No Response)

**********

Reviewer #1: (No Response)

Reviewer #3: The MS titled "Monitoring of Cd and GSH Contents and Bn-OASTL Expression in Transgenic Tobacco Seedlings in Response to Cd Stress" has been well revised. And I have no additional comment.

Reviewer #4: (No Response)

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Hucheng XING

Reviewer #3: No

Reviewer #4: No

**********

Formally Accepted
Acceptance Letter - Debasis Chakrabarty, Editor

PONE-D-25-39819R1

PLOS One

Dear Dr. He,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Debasis Chakrabarty

Academic Editor

PLOS One

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .